SARS-CoV-2 cell entry and targeted antiviral development

SARS-CoV-2 cell entry and targeted antiviral development

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the pandemic coronavirus disease 2019 (COVID-19), which threatens human health and public safety. In the urgent campaign to develop anti-SARS-CoV-2 therapies, the initial entry step is one of the most appealing ta...

Full description

Bibliographic Details
Main Authors: Zinuo Chen, Ruikun Du, Jazmin M. Galvan Achi, Lijun Rong, Qinghua Cui
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Acta Pharmaceutica Sinica B
Subjects:
SARS-CoV-2
Cell entry
Spike protein
Antiviral development
Post-pandemic
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383521001726

Similar Items

Similar Items